Searched for
AJANTA PHARMA NUMBERS
Sunil Singhania-backed Abakkus Flexi Cap Fund increases stake in HDFC Bank, RIL and 29 others in MaySunil Singhania-backed Abakkus Flexi Cap Fund significantly increased its holdings in HDFC Bank and Reliance Industries during May. The fun...- More macro headwinds on the cards? Tackle them with core principles: 6 pharma stocks with upside potential of up to 28%There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...
- Sunil Singhania-backed Abakkus Flexi Cap Fund raises stake in HDFC Bank, RIL and 28 other stocks in MarchAbakkus Flexi Cap Fund, backed by Sunil Singhania, boosted its holdings in HDFC Bank and Reliance Industries in March. The fund also increa...
- May add pharma, hospitals stocks as we go forward: Dhananjay SinhaDhananjay Sinha of Systematix Group notes US tariffs impact on pharma. A correction is seen in US-exposed companies. Tariff investigation o...
- Q2 results today: Airtel, Sun Pharma among 173 companies to announce earnings on MondayToday, 173 companies will disclose their Q2 earnings, including Airtel, Sun Pharma, and Adani Power. Bharti Airtel is anticipated to post r...
- Ajanta Pharma shares jump over 13% on strong Q4 results, buyback plansAjanta Pharma shares jumped 13% to Rs 2,532 in Friday's trade on BSE after the firm's consolidated net profit increased 66% year-on-year (Y...
- Ajanta Pharma announces Rs 285 crore share buyback at 24% premiumAjanta Pharma on Thursday announced a Rs 285 crore buyback of up to 10.28 lakh shares through a tender offer at a price of Rs 2,770 — a pre...
- IRFC, MRF among 8 midcap stocks which hit new 52-week high on ThursdayAugust 3 witnessed a remarkable surge in the BSE MidCap segment as several stocks hit new 52-week highs, displaying strong bullish momentum...
- 60 smallcap stocks delivered double-digit returns in volatile market weekThangamayil Jewellery was the top gainer in the smallcap pack with over 50% return, followed by MSP Steel and Power (48.95%), Foseco India ...
- Ajanta Pharma announces Rs 315 crore share buyback. Details hereAjanta Pharma is a speciality pharmaceutical formulation company having branded generic business in India and emerging markets, generic bus...
- Ajanta Pharma board approves up to Rs 286-crore share buyback planThe total pay-out towards buyback of shares will be not exceeding Rs 356 crore, including a share buyback consideration not exceeding Rs 28...
- Ajanta Pharma Q2 results: Profit up 15% at Rs 196 croreRevenue from operations rose to Rs 885 crore in the second quarter as compared with Rs 716 crore in the year-ago period, Ajanta Pharma said...
- Ajanta Pharma earmarks Rs 250 crore capex for current fiscal"During the current year (FY22), we are estimating the capex to be in the vicinity of Rs 250 crore. It will largely go towards maintenance ...
- Market Movers: SBI, Sun Pharma rally post Q1 nos; RIL, HDFC fall; 70 stocks flash 'buy' signalsNifty saw a negative close for the third consecutive session whereas on the weekly chart it closed in the red after six positive weeks.
- Beaten-down pharma stocks turn healthy bets for investorsThe sector has managed to function during the lockdown and meet local and global demand.
- Stock pick of the week: Why Ajanta Pharma is analysts’ favouriteStrong export performance, increased capacity utilisation and expected revenue and profit boost have made Ajanta Pharma analysts’ top pick.
- Bullish on pharma sector: Dipan Mehta"Pharma is a great story to buy into but there are associated risks also attached with it," says Dipan Mehta.
- Expect decent upside for Ajanta Pharma over six-month horizon: Avinnash Gorakssakar, Miintdirect.comAvinnash Gorakssakar, Head of Research, Miintdirect.com, shares his views on Ajanta Pharma.
- Buy Ajanta Pharma for a target of 400: Avinnash GorakssakarThe stock is available at a multiple of just 6 times on FY12 and 5 times on FY13.
- Accumulate Natco Pharma and Ajanta Pharma: Vivek Mavani"Indian pharma companies say the likes of a Natco pharma or an Ajanta Pharma, look quite interesting."
Load More
